Bethea ED, Chen Q, Hur C, et al. Cost-effectiveness of Treating Acute versus Chronic Hepatitis C Infection Using Direct-Acting Antivirals. AASLD 2017, abstract 24.
Xalnesiran met of zonder immuunmodulator bij chronische hepatitis B
apr 2025 | Hepatitis, Virale infecties